James Ip, MD
Clinical Cardiac Electrophysiology · New York, NYNPI 1699709725
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $245,296 of the $346,777 with a category attached, or 70.7%. Abbott accounts for 75.3% of it on its own, with 16 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 398 payments — averaging $871.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$261K
- Medtronic$34K
- Biotronik Inc.$20K
- Boston Scientific$20K
- Edwards Lifesciences$4K
- Altathera Pharmaceuticals LLC$3K
- plus $5K from 11 others
Across 67 payments — averaging $13,389 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$781K
- ZOLL Respicardia, Inc.$43K
- Medtronic$37K
- Impulse Dynamics (USA) Inc.$36K
What the payments were for
- Consulting fees$245,29671%
- Speaking & faculty fees$37,79511%
- Travel & lodging$55,05216%
- Food & beverage$8,5342%
- Entertainment$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 283 | $261,121 |
| Medtronic(2 entities) | 33 | $33,815 |
| Biotronik Inc. | 38 | $20,331 |
| Boston Scientific | 17 | $19,837 |
| Edwards Lifesciences | 1 | $3,500 |
| Altathera Pharmaceuticals LLC | 3 | $3,418 |
| EBR Systems, Inc. | 10 | $2,499 |
| Philips North America LLC | 3 | $1,367 |
| Sanofi-aventis U.S. LLC | 1 | $400 |
| Biosense Webster, Inc. | 2 | $130 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $99 |
| Stereotaxis Inc | 1 | $99 |
| ZOLL Respicardia, Inc. | 1 | $45 |
| Atricure, Inc. | 1 | $37 |
| Johnson & Johnson | 1 | $31 |
| Impulse Dynamics (USA) Inc. | 1 | $27 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$184,906
- ALLURE$22,093
- EMBLEM MRI S-ICD$9,698
- Nanostim Leadleas Pacemaker$4,997
- ACCENT$4,675
- Sotalol Hydrochloride$3,418
- CLINICAL TRIAL PRODUCT$1,750
- TightRail$1,325
- TENDRIL$825
- Micra$441
- MULTAQ$400
- BioMonitor$302
- Cardiovascular- Research only$281
- Evera$202
- Visia AF$152
- TYRX$122
How this compares
$346,777 in reported general payments places this provider in the 95th percentile of 214 clinical cardiac electrophysiology providers in New York.
See all clinical cardiac electrophysiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 70 | $64,701 |
| XareltoRivaroxaban | 37 | $29,768 |
| Dofetilide | 51 | $19,025 |
| Metoprolol Succinate | 165 | $3,623 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 42 | $1,370 |
| Diltiazem 24hr Er (Xr)Diltiazem Hcl | 12 | $529 |
| Flecainide Acetate | 13 | $398 |
| Amiodarone Hcl | 12 | $346 |
| Amlodipine Besylate | 11 | $119 |
| Metoprolol Tartrate | 16 | $107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $31 | $29,76837 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 214 clinical cardiac electrophysiology providers in New York.
Other clinical cardiac electrophysiology in New York
- Vivek ReddyNew York$14.9M
- Jacob KoruthNew York$3.7M
- Srinivas DukkipatiNew York$2.7M
- Amir AhmadiNew York$789K
- Larry ChinitzNew York$448K
- Nicholas SkipitarisNew York$293K
- Mohit TuragamNew York$202K
- David LauNew York$202K
- Christopher LiuNew York$181K
- Chirag BarbhaiyaNew York$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.